Table 3 Secondary outcomes
| Â | AT | Control | Relative risk | 95% confidential interval |
|---|---|---|---|---|
Subjects | 2864 | 2864 | Â | Â |
Bleeding and thrombosis-related surgical outcomes | ||||
  Intraoperative severe bleedinga | 229 (8.0%) | 194 (6.8%) | 1.18 | 0.98–1.42 |
  Intraoperative transfusion | 1020 (35.6%) | 865 (30.2%) | 1.18 | 1.09–1.27 |
  Bleeding complication | 145 (5.1%) | 110 (3.8%) | 1.32 | 1.03–1.68 |
  Thrombotic complication | 127 (4.4%) | 102 (3.6%) | 1.25 | 0.96–1.61 |
  Postoperative transfusion | 711 (24.8%) | 625 (21.8%) | 1.14 | 1.04–1.25 |
Other postoperative outcomes | ||||
  Mortality | 664 (23.2%) | 662 (23.1%) | 1.00 | 0.91–1.10 |
  Infectious complication | ||||
   Severe sepsis/ septic shock | 567 (19.8%) | 539 (18.8%) | 1.05 | 0.95–1.17 |
   Surgical site infection | 880 (30.7%) | 837 (29.2%) | 1.05 | 0.97–1.14 |
   Pneumonia | 421 (14.7%) | 407 (14.2%) | 1.03 | 0.91–1.17 |
   Urinary tract infection | 116 (4.1%) | 109 (3.8%) | 1.06 | 0.82–1.38 |
Duration of operation (minutes) | 129 (95–175) | 125 (92–168) | - | - |
ICU length of stay | 5 (3–11) | 5 (3–11) | - | - |
Hospital length of stay | 31 (16–54) | 32 (18–57) | - | - |